Pharmacogenetics of the systemic treatment in advanced hepatocellular carcinoma

Hepatocellular carcinoma (HCC) accounts for the majority of primary liver cancers. To date, most patients with HCC are diagnosed at an advanced tumor stage, excluding them from potentially curative therapies (i.e., resection, liver transplantation, percutaneous ablation). Treatments with palliative...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:World J Gastroenterol
Asıl Yazarlar: De Mattia, Elena, Cecchin, Erika, Guardascione, Michela, Foltran, Luisa, Di Raimo, Tania, Angelini, Francesco, D’Andrea, Mario, Toffoli, Giuseppe
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Baishideng Publishing Group Inc 2019
Konular:
Review
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6689804/
https://ncbi.nlm.nih.gov/pubmed/31413525
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v25.i29.3870
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller